Latest news
Promising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.comnews.cancerconnect.com · Mon, 03 Aug 2026 17:25:49 GMTClaudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer - OncodailyOncodaily · Sat, 01 Aug 2026 09:06:02 GMTAstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 20:25:00 GMTMary Lou Claudin Obituary (2026) - Washington, IL - Deiters Funeral Home & Crematory, Ltd. - Washington - Legacy obituaryLegacy obituary · Mon, 27 Jul 2026 19:04:40 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMT